| scholarly article | Q13442814 |
| P356 | DOI | 10.3171/JNS.1989.70.2.0240 |
| P698 | PubMed publication ID | 2783608 |
| P50 | author | Edward H. Oldfield | Q90685730 |
| P2093 | author name string | Wilson D | |
| Greenfield L | |||
| Johnson VG | |||
| Zovickian J | |||
| Youle R | |||
| Wrobel C | |||
| P2860 | cites work | A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 240-248 | |
| P577 | publication date | 1989-02-01 | |
| P1433 | published in | Journal of Neurosurgery | Q15708886 |
| P1476 | title | Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia | |
| P478 | volume | 70 |
| Q48951049 | Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate |
| Q34087862 | Brain tumors in the older person |
| Q36851197 | Carcinomatous meningitis: Leptomeningeal metastases in solid tumors |
| Q72480257 | Cerebellar medulloblastomas in adults |
| Q34782295 | Clinical development of experimental therapies for malignant glioma. |
| Q67926659 | Comparison of protein synthesis inhibition kinetics and cell killing induced by immunotoxins |
| Q38744447 | Convection-Enhanced Delivery |
| Q70466250 | Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb |
| Q54221714 | Cytotoxic effect of diphtheria toxin used alone or in combination with other agents on human renal cell carcinoma cell lines. |
| Q38108516 | Diphtheria toxin-based targeted toxin therapy for brain tumors |
| Q48094101 | Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics |
| Q35118933 | Gene therapy and targeted toxins for glioma |
| Q57006162 | Gene therapy and targeted toxins for glioma |
| Q41823737 | Heterogeneous response of individual multicellular tumour spheroids to immunotoxins and ricin toxin |
| Q72276322 | High-yield production of diphtheria toxin mutants by high-density culture of C7 (beta)tox+ strains grown in a non-deferrated medium |
| Q35210454 | Immunotoxin therapy for CNS tumor |
| Q72374005 | Immunotoxin therapy of leptomeningeal neoplasia |
| Q41124112 | Immunotoxin therapy. |
| Q36725728 | Immunotoxins and central nervous system neoplasia |
| Q34646650 | Immunotoxins for targeted cancer therapy |
| Q41340290 | In Vitro and In Vivo Variation in Transferrin Receptor Expression on a Human Medulloblastoma Cell Line |
| Q41119145 | In vitro efficacy of transferrin-toxin conjugates against glioblastoma multiforme |
| Q36910686 | In vivo T-cell ablation by a holo-immunotoxin directed at human CD3 |
| Q45714399 | Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals |
| Q48598762 | Intraventricular immunotoxin therapy for leptomeningeal neoplasia |
| Q36282162 | Leptomeningeal metastases from solid malignancy: a review |
| Q36824142 | Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate |
| Q46420117 | Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy |
| Q36796882 | Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy |
| Q36272990 | New delivery approaches for pediatric brain tumors |
| Q72116673 | Nude rat models for human tumor metastasis to CNS. Procedures for intracarotid delivery of cancer cells and drugs |
| Q91639486 | Production and Evaluation of an Avian IgY Immunotoxin against CD133+ for Treatment of Carcinogenic Stem Cells in Malignant Glioma: IgY Immunotoxin for the Treatment of Glioblastoma |
| Q28299886 | RTVP-1, a novel human gene with sequence similarity to genes of diverse species, is expressed in tumor cell lines of glial but not neuronal origin |
| Q41284068 | Self-potentiation of ligand-toxin conjugates containing ricin A chain fused with viral structures |
| Q37359369 | Systemic immunotoxin therapy of cancer: advances and prospects |
| Q58008126 | Targeted therapeutic RNases (ImmunoRNases) |
| Q35999648 | Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation. |
| Q37954275 | Targeted toxins in brain tumor therapy |
| Q38686601 | The future of antiviral immunotoxins |
| Q36406637 | The transferrin receptor and the targeted delivery of therapeutic agents against cancer. |
| Q27006226 | Toxin-based targeted therapy for malignant brain tumors |
| Q27013664 | Toxin-based therapeutic approaches |
| Q55484164 | Transferrin Receptor on Glioblastoma Multiforme |
| Q67289257 | Transferrin receptor expression in tumours of the human nervous system: relation to tumour type, grading and tumour growth fraction |
| Q30885145 | Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas |
| Q40745587 | Transferrin toxin but not transferrin receptor immunotoxin is influenced by free transferrin and iron saturation |
| Q48587395 | Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors |
Search more.